South Korea — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

← back to leaderboard

South Korea received 27 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 6 in 2024-Q1, with the trend rising sharply year-on-year. The most-cited issues are unapproved, no english, and nutrit lbl. No trade baseline is published for this commodity from South Korea, so no per-$1B rate is shown here.

Of these, 10 were hazard refusals and 17 were paperwork refusals.

Exporting from South Korea? Get an email when shipments from South Korea are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 6 2024-Q1 2024-Q1: 6 2 2024-Q2 2024-Q2: 2 0 2024-Q3 2024-Q3: 0 1 2024-Q4 2024-Q4: 1 0 2025-Q1 2025-Q1: 0 0 2025-Q2 2025-Q2: 0 2 2025-Q3 2025-Q3: 2 3 2025-Q4 2025-Q4: 3 4 2026-Q1 2026-Q1: 4 3 2026-Q2 2026-Q2: 3 4 2026-Q3 2026-Q3: 4

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Supplements 15 unapproved
Herbals-Botanicals 12 ncontact

Recent rejections